ImmunoPrecise Antibodies Ltd. (OTCMKTS:IPATF – Get Free Report)’s share price traded down 5% during mid-day trading on Tuesday . The stock traded as low as $0.41 and last traded at $0.42. 1,129,925 shares were traded during mid-day trading, an increase of 5,459% from the average session volume of 20,327 shares. The stock had previously closed at $0.44.
ImmunoPrecise Antibodies Trading Down 5.0 %
The stock’s 50 day moving average is $0.47 and its 200 day moving average is $0.55.
About ImmunoPrecise Antibodies
ImmunoPrecise Antibodies Ltd. engages in the provision of human therapeutic antibody discovery and development services. It offers a selection of antibodies, enzymes, enzymes activity assays, arthritis animal products, proteins, deiminated proteins, and hybridoma licensing for research purposes. Its services include B cell sorting, screening and sequencing; custom, immune and naive phage display production and screening; bi-specific, tri-specific, VHH, and VNAR antibody manufacturing; antibody engineering; and antibody optimization and humanization.
Further Reading
- Five stocks we like better than ImmunoPrecise Antibodies
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Hims & Hers Earnings Could Be a Game Changer—What to Do Now
- How to Use the MarketBeat Stock Screener
- DeepSeek IPO Remains Far Off—Investors Eye 4 Chinese AI Stocks
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Mortgage Market Bottom? Why Rocket Companies Could Be a Buy
Receive News & Ratings for ImmunoPrecise Antibodies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmunoPrecise Antibodies and related companies with MarketBeat.com's FREE daily email newsletter.
